(Q38037157)

27 August 2017

Plasma biomarkers for Alzheimer's disease: much needed but tough to find (English)

1 reference

27 August 2017

0 references

0 references

Simon Lovestone

2

0 references

author name string

Chantal Bazenet

series ordinal

1

1 reference

27 August 2017

1 August 2012

1 reference

27 August 2017

Biomarkers in Medicine

1 reference

27 August 2017

6

1 reference

27 August 2017

4

1 reference

27 August 2017

441-454

1 reference

2012 Alzheimer's disease facts and figures

27 August 2017

1 reference

Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design

21 January 2018

1 reference

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

21 January 2018

1 reference

Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

21 January 2018

1 reference

Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease

21 January 2018

1 reference

Biomarkers for Alzheimer's disease therapeutic trials

21 January 2018

1 reference

Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset

21 January 2018

1 reference

Clinical trial methodologies for disease-modifying therapeutic approaches

21 January 2018

1 reference

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

Are biomarkers harmful to recruitment and retention in Alzheimer's disease clinical trials? An international perspective.

21 January 2018

1 reference

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

21 January 2018

1 reference

Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.

21 January 2018

1 reference

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

21 January 2018

1 reference

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

21 January 2018

1 reference

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease

21 January 2018

1 reference

21 January 2018

1 reference

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease

21 January 2018

1 reference

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants

21 January 2018

1 reference

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

21 January 2018

1 reference

Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.

21 January 2018

1 reference

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

21 January 2018

1 reference

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

21 January 2018

1 reference

A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease

21 January 2018

1 reference

Proteomic research in psychiatry

21 January 2018

1 reference

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

A serum protein-based algorithm for the detection of Alzheimer disease

21 January 2018

1 reference

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

21 January 2018

1 reference

A blood-based algorithm for the detection of Alzheimer's disease

21 January 2018

1 reference

Proteome-based plasma biomarkers for Alzheimer's disease

21 January 2018

1 reference

Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.

21 January 2018

1 reference

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

21 January 2018

1 reference

Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer's disease

21 January 2018

1 reference

Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease.

21 January 2018

1 reference

Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease

21 January 2018

1 reference

Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.

21 January 2018

1 reference

Metabolomics: a global biochemical approach to the study of central nervous system diseases

21 January 2018

1 reference

Metabolomics tools for identifying biomarkers for neuropsychiatric diseases

21 January 2018

1 reference

Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease

21 January 2018

1 reference

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

21 January 2018

1 reference

Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry

21 January 2018

1 reference

Serum sphingomyelins and ceramides are early predictors of memory impairment

21 January 2018

1 reference

Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology

21 January 2018

1 reference

Analysis of the adult human plasma metabolome

21 January 2018

1 reference

Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes

21 January 2018

1 reference

Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples

21 January 2018

1 reference

Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics

21 January 2018

1 reference

Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry

21 January 2018

1 reference

Metabolome in progression to Alzheimer's disease

21 January 2018

1 reference

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study

21 January 2018

1 reference

The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease

21 January 2018

1 reference

3alpha,5alpha-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia

21 January 2018

1 reference

A high confidence, manually validated human blood plasma protein reference set

21 January 2018

1 reference

Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.

21 January 2018

1 reference

A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses

21 January 2018

1 reference

A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells

21 January 2018

1 reference

Alterations of the microRNA network cause neurodegenerative disease.

21 January 2018

1 reference

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

21 January 2018

1 reference

Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus.

21 January 2018

1 reference

Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome

21 January 2018

1 reference

Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics

21 January 2018

1 reference

Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows

21 January 2018

1 reference

Oxidative stress hypothesis in Alzheimer's disease: a reappraisal

21 January 2018

1 reference

The role of inflammation in Alzheimer's disease

21 January 2018

1 reference

Identification of oxidized plasma proteins in Alzheimer's disease

21 January 2018

1 reference

Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits

21 January 2018

1 reference

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma

21 January 2018

1 reference

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution

21 January 2018

1 reference

Plasma biomarkers of brain atrophy in Alzheimer's disease

21 January 2018

1 reference

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

21 January 2018

1 reference

Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

Hippocampal function in healthy carriers of the CLU Alzheimer's disease risk variant.

21 January 2018

1 reference

Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk

21 January 2018

1 reference

Proteomic analyses of human plasma: Venus versus Mars

21 January 2018

1 reference

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry

21 January 2018

1 reference

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

21 January 2018

1 reference

Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease

21 January 2018

1 reference

Liquid Chromatography-Mass Spectrometry (LC-MS)-Based Lipidomics for Studies of Body Fluids and Tissues

21 January 2018

1 reference

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease

21 January 2018

1 reference

Biomarkers for Alzheimer’s disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.12.48

1 reference

27 August 2017

1 reference

PubMed ID

22917146